Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran etexilate vs Warfarin in Cerebral Venous Thrombosis (DE-CVT)
NCT03217448Phase 3Unknown
- Sponsor
- Capital Medical University
- Start
- Oct 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dabigatran in Cerebral venous thrombosis (CVT), sponsored by Capital Medical University. Status: unknown.
02
Drugs
dabigatran
03
Conditions
Cerebral venous thrombosis (CVT)
Beyond the preview
Go deeper on NCT03217448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03217448.